Drug discovery pact between Charles River and Valo Health nets potential ... covered by the wide-ranging partnership is to address unmet needs within Pfizer’s core strategic areas of interest.

Collaboration leverages Logica, a platform offering from Valo Health and Charles ... signed under strategic partnership between Flagship Pioneering and Pfizer to accelerate discovery of ...

Pfizer and Flagship will engage Charles River Laboratories to leverage Logica, an artificial intelligence (AI)-powered platform offering from Flagship-founded Valo Health ... “Through the power of our ...

Pfizer (PFE) and Pioneering Medicines ... a platform offering from Valo Health, a Flagship-founded company, to identify advanceable small molecule leads. Logica translates biological insights ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic diseases, leveraging AI and extensive human datasets.

Pfizer is partnering with Flagship Pioneering ... 1 Charles River Laboratories will begin utilizing digital health platform Logica to identify new molecule leads. Logica is owned by Flagship’s Valo ...

Novo Nordisk gets a license to three preclinical-stage cardiovascular disease programmes from Valo Health in return for its initial investment and is prepared to expand the partnership to cover 11 ...

Valo Health, Inc. (“Valo”), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today ...